John P. Sharp
2013 - Ligand Pharmaceuticals
In 2013, John P. Sharp earned a total compensation of $732.7K as Former VP, Finance and Chief Financial Officer at Ligand Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $96,390 |
|---|---|
| Option Awards | $277,362 |
| Salary | $301,220 |
| Stock Awards | $54,800 |
| Other | $2,946 |
| Total | $732,718 |
Sharp received $301.2K in salary, accounting for 41% of the total pay in 2013.
Sharp also received $96.4K in non-equity incentive plan, $277.4K in option awards, $54.8K in stock awards and $2.9K in other compensation.
Rankings
In 2013, John P. Sharp's compensation ranked 7,920th out of 12,286 executives tracked by ExecPay. In other words, Sharp earned more than 35.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,920 out of 12,286 | 36th |
Division Manufacturing | 2,865 out of 4,612 | 38th |
Major group Chemicals And Allied Products | 890 out of 1,462 | 39th |
Industry group Drugs | 673 out of 1,156 | 42nd |
Industry Pharmaceutical Preparations | 534 out of 890 | 40th |
Source: SEC filing on March 12, 2015.
Sharp's colleagues
We found four more compensation records of executives who worked with John P. Sharp at Ligand Pharmaceuticals in 2013.